Pro Share Advisors LLC Eagle Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$44.58 - $52.6 $208,366 - $245,852	-4,674 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$45.82 - $56.9 $4,123 - $5,121	90 Added 1.96%	4,674 $238,000
Q3 2021 Nov 12, 2021	SELL	$43.79 - $55.78 $48,256 - $61,469	-1,102 Reduced 19.38%	4,584 $256,000
Q2 2021 Aug 13, 2021	BUY	$36.86 - $44.5 $28,308 - $34,176	768 Added 15.62%	5,686 $243,000
Q1 2021 May 14, 2021	BUY	$40.32 - $50.97 $15,442 - $19,521	383 Added 8.45%	4,918 $205,000
Q4 2020 Feb 09, 2021	BUY	$41.72 - $51.34 $189,200 - $232,826	4,535 New	4,535 $211,000
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $153,565 - $268,392	-4,468 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$54.32 - $64.31 $28,518 - $33,762	-525 Reduced 10.51%	4,468 $268,000
Q3 2019 Nov 12, 2019	SELL	$53.25 - $59.98 $25,826 - $29,090	-485 Reduced 8.85%	4,993 $282,000
Q2 2019 Aug 13, 2019	SELL	$46.61 - $58.45 $32,673 - $40,973	-701 Reduced 11.34%	5,478 $305,000
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $11,520 - $15,442	-298 Reduced 4.6%	6,179 $312,000
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $45,422 - $83,782	-1,237 Reduced 16.04%	6,477 $261,000
Q3 2018 Nov 14, 2018	SELL	$66.65 - $83.86 $10,930 - $13,753	-164 Reduced 2.08%	7,714 $535,000
Q2 2018 Aug 13, 2018	SELL	$51.25 - $76.62 $14,298 - $21,376	-279 Reduced 3.42%	7,878 $596,000
Q1 2018 May 14, 2018	SELL	$52.16 - $66.86 $69,320 - $88,856	-1,329 Reduced 14.01%	8,157 $430,000
Q4 2017 Feb 14, 2018	BUY	$49.6 - $60.87 $10,465 - $12,843	211 Added 2.27%	9,486 $507,000
Q3 2017 Nov 13, 2017	BUY	$46.62 - $60.36 $26,899 - $34,827	577 Added 6.63%	9,275 $553,000
Q2 2017 Aug 11, 2017	BUY	N/A	8,698	8,698 $686,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account